During the past decade, Oncology Hematology Associates of Central Illinois, PC - Ottawa conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 73 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 70 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Eastern Cooperative Oncology Group" with 9 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "Radiation Therapy Oncology Group" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" #1 collaborator was "National Cancer Institute (NCI)" with 108 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" are "Breast Cancer" (29 trials), "Lymphoma" (16 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials), "Lung Cancer" (11 trials) and "Leukemia" (8 trials). Many other conditions were trialed in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" are "Drug" (86 trials), "Other" (37 trials), "Biological" (35 trials), "Radiation" (19 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (26 trials), "bevacizumab" (11 trials), "carboplatin" (11 trials), "cyclophosphamide" (11 trials) and "rituximab" (11 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates of Central Illinois, PC - Ottawa" are 87 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates of Central Illinois, PC - Ottawa". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Oncology Hematology Associates of Central Illinois, PC - Ottawa, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates of Central Illinois, PC - Ottawa, 6 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".